Tas-102(Suyuan) combined with bevacizumab
MT-006
Phase 2 small_molecule active
Quick answer
Tas-102(Suyuan) combined with bevacizumab for Colorectal Cancer is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active